DOI: 10.1055/s-00034925

Hämostaseologie

References

Kiessling P, Lledo-Garcia R, Watanabe S. , et al.
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: a randomized phase 1 study.

Sci Transl Med 2017;
9 (414) eaan1208

Download Bibliographical Data

Search in:
Access: